Table I.
Demographic and clinical characteristics of patients.
| Variables | Value |
|---|---|
| Gender | |
| Male, n (%) | 16 (57.1) |
| Female, n (%) | 12 (42.9) |
| Age, yearsa | 65 (43–83) |
| Tumor location | |
| Head, n (%) | 15 (53.6) |
| Body-Tail, n (%) | 13 (46.4) |
| CA19-9, U/mlb | 851.4 (14.5–3,765.0) |
| CEA, ng/mlb | 5.3 (2.6–14.6) |
| TNM stage | |
| I, n (%) | 4 (14.3) |
| II, n (%) | 9 (32.1) |
| III, n (%) | 15 (53.6) |
a
Data are presented as the mean (range).
b
Data are presented as the median (interquartile range). CA19-9, cancer antigen 19-9; CEA, carcinoembryonic antigen; TNM, Tumor-Node-Metastasis.